BehfarEhdaieMDMPH

Surgical Oncology

Assistant Professor

Overview of Dr. Ehdaie

Dr. Behfar Ehdaie is an urologist in New York, NY and is affiliated with multiple hospitals in the area, including Memorial Sloan Kettering Cancer Center and Memorial Hospital for Cancer and allied Diseases. He received his medical degree from Georgetown University School of Medicine and has been in practice 12 years. He is one of 76 doctors at Memorial Sloan Kettering Cancer Center and one of 16 doctors at Memorial Hospital for Cancer and allied Diseases who specialize in Urology. He has more than 100 publications and over 500 citings.

Office
353 East 68th Street
New York, NY 10065
Book by Phone+1(559) 370-3010

Education & Training

University of Virginia Medical CenterResidency, Urology, 2006 - 2010
University of Virginia Medical CenterInternship, Transitional Year, 2005 - 2006
Georgetown University School of MedicineClass of 2005

Certifications & Licensure

NY State Medical License 2010 - 2025
NJ State Medical License 2021 - 2023
VA State Medical License 2005 - 2010
American Board of Urology Urology

Awards, Honors, & Recognition

Chief Admistrative Fellow Memorial Sloan Kettering Cancer Center
Alpha Omega Alpha Georgetown University School of Medicine
Prostate Cancer Foundation Award Society of Urologic Oncology

Clinical Trials

Early Staged Consent Before Prostate Biopsy Start of enrollment: 2018 Apr 11
Active, not recruiting
Not Applicable
A Study on the Effects of Exercise Therapy on Signs of Prostate Cancer Start of enrollment: 2023 Feb 10
Recruiting
Phase 2
Roles: Contact

Publications & Presentations

PubMed

Neoadjuvant Exercise Therapy in Patients With Prostate Cancer-Reply.
Lee W Jones, Behfar Ehdaie, Paul C Boutros
JAMA Oncology. 2024-12-05
Quantification of Gleason Pattern 4 Metrics Identifies Pathologic Progression in Patients With Grade Group 2 Prostate Cancer on Active Surveillance.
Marlon Perera, Melissa Assel, Sunny Nalavenkata, Sari Khaleel, Nicole Benfante
Clinical Genitourinary Cancer. 2024-12-01
Targeted Ablation Using Ultrasound-Guided Irreversible Electroporation of Index Tumors (TARGET Study): Prospective Development Study Evaluating Safety, Patient-Reporte...
Jonathan Fainberg, Taehyoung Lee, Emily A Vertosick, Arjun Sivaraman, Gregory Chesnut
Urology Practice. 2024-11-01

Lectures

Outcomes of men with prostate cancer managed with active surveillance and tested with clinical cell-cycle risk score.
2019 ASCO Annual Meeting - 6/1/2019

Press Mentions

The Best (And Worst) Foods for Prostate HealthSeptember 24th, 2024
Prostate MRI-Bx May ID Partial Gland Ablation CandidatesSeptember 1st, 2017
Long-Term, Surgery for Localized Prostate Cancer Offers Little Extra BenefitJuly 12th, 2017
Join now to see all